Are There Hints Danaher Will Have a Better Than Expected 2020?
Life sciences and diagnostics company Danaher (NYSE: DHR) had a great 2019, and if the early indications for 2020 are anything to go by, investors can expect the same this year. The company has strong earnings momentum, and its stock should be considered as an option for investors looking for a defensive growth option. Let's take a closer look at what's going on.
Image source: Getty Images.
Here are three reasons:
Source Fool.com
